UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
/PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease...
Los Angeles United States Hannah Davis Nicholas Stanzione Michaelj Donovan Clinical Laboratory Improvement Amendments
Source: prnewswire.com